Chidamide, Azacitidine Combined With GM Regimen for Relapsed and Refractory DLBCL Patients

NCT05823701 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma

Interventions

DRUG: Chidamide
DRUG: Azacitidine
BIOLOGICAL: obinutuzumab
DRUG: Liposomal mitoxantrone

Sponsor

The First Affiliated Hospital of Soochow University